Supernus Pharmaceuticals SUPN Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Supernus Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Supernus Pharmaceuticals’s 10-Q, filed August 5, 2025, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Supernus Pharmaceuticals's free cash flow margin?
- Supernus Pharmaceuticals (SUPN) reported free cash flow margin of 27.9% in Q2 2025.
- How has Supernus Pharmaceuticals's free cash flow margin changed year-over-year?
- Supernus Pharmaceuticals's free cash flow margin increased by 14.0% year-over-year, from 24.5% to 27.9%.
- What is the long-term trend for Supernus Pharmaceuticals's free cash flow margin?
- Over 2 years (2020 to 2024), Supernus Pharmaceuticals's free cash flow margin has grown at a -0.1% compound annual growth rate (CAGR), from 25.9% to 25.9%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.